Evaluation of the PhageTech Virus BioResistor

BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT02657486 ·Status: COMPLETED ·Phase: NA

Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma

NCT01878188 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

NCT03528694 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Molecular Analysis Of Bladder Cancer

NCT00871754 ·Status: ACTIVE_NOT_RECRUITING

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder

NCT06289283 ·Status: ACTIVE_NOT_RECRUITING

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

NCT02311101 ·Status: COMPLETED ·Phase: PHASE1

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

NCT05037279 ·Status: RECRUITING ·Phase: PHASE3

The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial

NCT07257718 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma

NCT02647112 ·Status: COMPLETED ·Phase: NA

Bladder Cancer Screening Trial

NCT05646485 ·Status: RECRUITING ·Phase: NA

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

NCT04723121 ·Status: COMPLETED ·Phase: NA

Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder

NCT02745301 ·Status: COMPLETED

Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer

NCT02143804 ·Status: WITHDRAWN ·Phase: PHASE2

Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy

NCT06986304 ·Status: RECRUITING

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

NCT05982561 ·Status: RECRUITING

Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases

NCT06870253 ·Status: ACTIVE_NOT_RECRUITING

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

NCT06020807 ·Status: COMPLETED

Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer

NCT06732531 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

NCT04452591 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Biological Therapy in Treating Patients With Bladder Cancer

NCT00003779 ·Status: COMPLETED ·Phase: PHASE3

BCG for Therapeutic Use Phase Ⅲ Clinical Trial

NCT06747455 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.

NCT06289270 ·Status: RECRUITING

Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer

NCT05675176 ·Status: COMPLETED

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

NCT06567743 ·Status: RECRUITING ·Phase: PHASE2

Prognostic Biomarkers in Patients With Urothelial Carcinoma

NCT04872036 ·Status: COMPLETED